Table 4 Changes in utility measures at 2 yrs by presence or absence of Serious Adverse Event episodes
Serious Adverse Event episodes (in 2-year period) | Dolan | Shaw | Brazier SF6D (SF12) | Brazier SF6D (SF36) | Lundberg | Lawrence | Franks MEPS | Franks | Fryback | |
|---|---|---|---|---|---|---|---|---|---|---|
NO | Mean difference* | -.024 | -.017 | -.019 | -.019 | -.021 | -.023 | -.022 | -.018 | -.013 |
Std. Deviation | .196 | .139 | .115 | .121 | .078 | .142 | .146 | .146 | .068 | |
YES | Mean difference* | -.042 | -.028 | -.035 | -.031 | -.037 | -.046 | -.052 | -.058 | -.015 |
Std. Deviation | .230 | .157 | .127 | .125 | .087 | .156 | .173 | .190 | .068 | |
Regression coeff** (P value) | -.040 (.003) | -.028 (.003) | -.033 (<.001) | -.032 (<.001) | -.024 (<.001) | -.046 (<.001) | -.053 (<.001) | -.062 (<.001) | -.017 (<.001) | |
Signal/Noise ratio | .090 | .082 | .136 | .104 | .202 | .161 | .205 | .277 | .037 | |